Trade Summary

3 days ago, Trimarchi Thomas, serving as Pres, CFO at Bridgebio Pharma, Inc. (BBIO), sold 13,651 shares at $65.08 per share, for a total transaction value of $888,419.00. Following this transaction, Trimarchi Thomas now holds 359,194 shares of BBIO.

This sale represents a 4.00% decrease in Trimarchi Thomas's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:30 PM ET, 1 day after the trade was made.

Bridgebio Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.